tm
Seeing Is Believing
tm
Seeing Is Believing
Kindred Biosciences's activity chart (see below) currently has 37 price targets and 34 ratings on display.
Analysts average stock forecasts to be materialized ratio is 46.35% with an average time for these price targets to be met of 177.62 days.
Most recent stock forecast was given by BEN HAYNOR from ALLIANCE GLOBAL PARTNERS on 23-Aug-2021. First documented stock forecast 15-Nov-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Aug-2017
$15.25
5 years 1 months 6 days ago
(23-Aug-2021)
2/4 (50%)
$10.95 (254.65%)
332
Buy Since 17-Nov-2017
$9
5 years 3 months 12 days ago
(17-Jun-2021)
3/6 (50%)
$4.66 (107.37%)
172
Buy Since 24-Jul-2018
$9.25
5 years 3 months 13 days ago
(16-Jun-2021)
1/5 (20%)
$0.02 (0.22%)
69
Buy Since 10-Apr-2019
$9.25
$16
5 years 3 months 13 days ago
(16-Jun-2021)
1/3 (33.33%)
$0.02 (0.22%)
69
Buy Since 23-May-2019
$9
$-0.25 (-2.70%)
$13
5 years 4 months 17 days ago
(12-May-2021)
1/3 (33.33%)
$4.7 (109.30%)
35
What is KIN (Kindred Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on KIN (Kindred Biosciences)?
Which analyst has the most public recommendations on KIN (Kindred Biosciences)?
Which analyst is the currently most bullish on KIN (Kindred Biosciences)?
Which analyst is the currently most reserved on KIN (Kindred Biosciences)?
